Skip to main navigation Skip to search Skip to main content

Antibodies to nodal/paranodal proteins in paediatric immune-mediated neuropathy

  • Desiree De Simoni
  • , Gerda Ricken
  • , Michael Winklehner
  • , Inga Koneczny
  • , Michael Karenfort
  • , Ulf Hustedt
  • , Ulrich Seidel
  • , Omar Abdel-Mannan
  • , Pinki Munot
  • , Simon Rinaldi
  • , Claudia Steen
  • , Michael Freilinger
  • , Markus Breu
  • , Rainer Seidl
  • , Markus Reindl
  • , Julia Wanschitz
  • , Cinta Lleixà
  • , Günther Bernert
  • , Klaus-Peter Wandinger
  • , Ralf Junker
  • Luis Querol, Frank Leypoldt, Kevin Rostásy, Romana Höftberger

Research output: Journal article (peer-reviewed)Journal article

Abstract

Patients with nodal/paranodal antibodies represent a specific subgroup of inflammatory peripheral neuropathies, whose clinical presentation with a prolonged subacute phase, additional symptoms such as ataxia and tremor, and poor treatment response to IV immunoglobulin (IVIG) often differs from classic Guillain-Barré syndrome (GBS) or chronic inflammatory demyelinating polyneuropathy (CIDP).1.

Original languageEnglish
Article numbere763
JournalNeurology: Neuroimmunology and NeuroInflammation
Volume7
Issue number4
DOIs
Publication statusPublished - 01 Jul 2020

Keywords

  • Adolescent
  • Autoantibodies
  • Cell Adhesion Molecules, Neuronal/immunology
  • Child
  • Child, Preschool
  • Female
  • Guillain-Barre Syndrome/immunology
  • Humans
  • Infant
  • Male
  • Nerve Growth Factors/immunology
  • Nodal Protein/immunology
  • Polyradiculoneuropathy, Chronic Inflammatory Demyelinating/immunology
  • Retrospective Studies

Fingerprint

Dive into the research topics of 'Antibodies to nodal/paranodal proteins in paediatric immune-mediated neuropathy'. Together they form a unique fingerprint.

Cite this